2/27
06:26 am
knsa
Kiniksa Pharmaceuticals International (KNSA) was upgraded by Zacks Research from "strong sell" to "hold".
Medium
Report
Kiniksa Pharmaceuticals International (KNSA) was upgraded by Zacks Research from "strong sell" to "hold".
2/27
01:44 am
knsa
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Medium
Report
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Volatility [Yahoo! Finance]
2/26
06:55 am
knsa
Kiniksa Pharmaceuticals, Ltd. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals, Ltd. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
Low
Report
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
2/25
10:24 am
knsa
Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wells Fargo & Company from $50.00 to $53.00. They now have an "overweight" rating on the stock.
Low
Report
Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wells Fargo & Company from $50.00 to $53.00. They now have an "overweight" rating on the stock.
2/25
08:42 am
knsa
Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wedbush from $50.00 to $53.00. They now have an "outperform" rating on the stock.
Low
Report
Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wedbush from $50.00 to $53.00. They now have an "outperform" rating on the stock.
2/24
01:06 pm
knsa
Kiniksa Pharmaceuticals International Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals International Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
07:30 am
knsa
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Medium
Report
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
2/23
07:33 am
knsa
Kiniksa Pharmaceuticals International PLC (KNSA) Q4 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals International PLC (KNSA) Q4 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
2/19
04:18 pm
knsa
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 [Yahoo! Finance]
2/19
04:01 pm
knsa
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Low
Report
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2/19
08:00 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $62.00 price target on the stock.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $62.00 price target on the stock.
1/24
05:09 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/15
07:46 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/13
09:03 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
Medium
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
1/12
07:30 am
knsa
Kiniksa Pharmaceuticals Provides Corporate Update
Medium
Report
Kiniksa Pharmaceuticals Provides Corporate Update
1/7
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference